Delivery Order SPE2DB22D1106-SPE2DB24FEJL8
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,070.94 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, an established pharmaceutical distributor. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure a wide range of essential pharmaceutical products and medical supplies for the Department of Defense worldwide. The current...
- This federal contract award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $2,715.72 contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm-fixed price agreement with a completion date of May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML pharmaceutical products. The $2,567.03 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,876.35 firm fixed price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp also holds a separate indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,370.24 firm fixed-price delivery order is for AIMOVIG 70 MG/ML AUTOINJECTORML, a medication, with a completion date of February 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,380.67 firm fixed-price delivery order is for the supply of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including various military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract is a firm fixed price delivery order with a ceiling value of $3,672.84 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no indicated set-aside designation. In addition to this specific...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,078.25 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a performance period through March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. This delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The $1,743.29 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEJL8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,000.90 firm fixed price delivery order is for the supply of the pharmaceutical product AIMOVIG 70 MG/ML AUTOINJECTORML. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/2/24 |